NO161559C - Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater. - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.

Info

Publication number
NO161559C
NO161559C NO840721A NO840721A NO161559C NO 161559 C NO161559 C NO 161559C NO 840721 A NO840721 A NO 840721A NO 840721 A NO840721 A NO 840721A NO 161559 C NO161559 C NO 161559C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
analogy procedure
triazold
derivatives
Prior art date
Application number
NO840721A
Other languages
English (en)
Norwegian (no)
Other versions
NO161559B (no
NO840721L (no
Inventor
Kenneth Richardson
Geoffrey Edward Gymer
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO840721L publication Critical patent/NO840721L/no
Publication of NO161559B publication Critical patent/NO161559B/no
Publication of NO161559C publication Critical patent/NO161559C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647Triazoles; Hydrogenated triazoles
    • A01N43/6531,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO840721A 1983-02-25 1984-02-24 Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater. NO161559C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838305377A GB8305377D0 (en) 1983-02-25 1983-02-25 Antifungal agents

Publications (3)

Publication Number Publication Date
NO840721L NO840721L (no) 1984-08-27
NO161559B NO161559B (no) 1989-05-22
NO161559C true NO161559C (no) 1989-08-30

Family

ID=10538659

Family Applications (1)

Application Number Title Priority Date Filing Date
NO840721A NO161559C (no) 1983-02-25 1984-02-24 Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.

Country Status (28)

Country Link
US (1) US4960782A (xx)
EP (1) EP0118245B1 (xx)
JP (1) JPS59193877A (xx)
KR (1) KR870000356B1 (xx)
AU (1) AU545660B2 (xx)
CA (1) CA1257276A (xx)
CS (1) CS241047B2 (xx)
DD (1) DD216457A5 (xx)
DE (1) DE3463655D1 (xx)
DK (2) DK160823C (xx)
ES (1) ES529992A0 (xx)
FI (1) FI80683C (xx)
GB (1) GB8305377D0 (xx)
GR (1) GR79816B (xx)
HK (1) HK32389A (xx)
HU (1) HU190545B (xx)
IE (1) IE57056B1 (xx)
IL (1) IL71042A (xx)
IN (1) IN161372B (xx)
NO (1) NO161559C (xx)
NZ (1) NZ207256A (xx)
PH (1) PH20060A (xx)
PL (1) PL142674B1 (xx)
PT (1) PT78128B (xx)
SG (1) SG6589G (xx)
SU (1) SU1405701A3 (xx)
YU (1) YU42634B (xx)
ZA (1) ZA841322B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3461637D1 (en) * 1983-02-16 1987-01-22 Pfizer Ltd Triazole antifungal agents
US4690942A (en) * 1983-12-20 1987-09-01 Ciba-Geigy Corporation 1-aryl-2-fluoro-2-azolyl alkanones, alkanols, esters, and ethers, composition containing them, and use of them to control phytopathogenic microorganisms
IE58738B1 (en) * 1984-09-05 1993-11-03 Ici Plc Antifungal azole compounds
EP0228995A1 (de) * 1985-12-20 1987-07-15 Ciba-Geigy Ag Mikrobizide
DE3825841A1 (de) * 1988-07-29 1990-02-01 Basf Ag 1-halogen-1-azolypropene und -methyloxirane und diese enthaltende fungizide
FR2661176B1 (fr) * 1990-04-20 1992-06-12 Adir Nouveau procede de preparation de la 1-(2,3,4-trimethoxybenzyl) piperazine en amination reductive.
DE4034352A1 (de) * 1990-10-29 1992-04-30 Basf Ag 1-halogen-1-azolylmethanderivate und diese enthaltende fungizide
TW210334B (xx) * 1990-12-12 1993-08-01 Ciba Geigy Ag
US5488035A (en) * 1991-12-06 1996-01-30 Pioneer Hi-Bred International, Inc. Peptide with inhibitory activity towards plant pathogenic fungi
JP3471831B2 (ja) * 1991-12-09 2003-12-02 富山化学工業株式会社 新規なトリアゾール誘導体およびその塩
US5360612A (en) * 1992-10-13 1994-11-01 Pfizer Inc. Pharmaceutical compositions containing triazole derivatives for rectal administration
EA025266B1 (ru) * 2011-06-23 2016-12-30 Ваймет Фармасьютикалс, Инк. Соединения, ингибирующие металлоферменты
CN104136427B (zh) * 2012-01-20 2017-03-01 威尔金制药有限公司 金属酶抑制剂化合物
TWI646088B (zh) * 2012-03-16 2019-01-01 維愛美製藥公司 金屬酶抑制劑化合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2918894A1 (de) * 1979-05-10 1980-11-20 Bayer Ag Fluorierte 1-triazolyl-butan-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
DE2938534A1 (de) * 1979-09-24 1981-04-23 Bayer Ag, 5090 Leverkusen Acylierte triazolyl-(gamma)-fluorpinakolyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
GB2078719B (en) * 1980-06-02 1984-04-26 Ici Ltd Heterocyclic compounds
DE3033592A1 (de) * 1980-09-06 1982-04-22 Bayer Ag, 5090 Leverkusen Fluorierte 1-azolyl-butan-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
DE3262386D1 (en) * 1981-06-06 1985-03-28 Pfizer Ltd Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
DE3210570A1 (de) * 1982-03-23 1983-10-06 Hoechst Ag 3-azolyl-1,2-diaryl-1-halogen-1-propene, ihre herstellung, ihre verwendung als pflanzenschutzmittel und diese verbindungen enthaltende praeparate
GR79307B (xx) * 1982-06-09 1984-10-22 Pfizer
US4510148A (en) * 1982-06-12 1985-04-09 Pfizer Inc. 2-Heterocyclic-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ols as antifungal agents
US4518604A (en) * 1983-07-25 1985-05-21 Pfizer Inc. Antifungal 1-aryl-2-(1H-1,2,4-triazol-1yl)-1-perfluoroalkylethyl halides
US4690942A (en) * 1983-12-20 1987-09-01 Ciba-Geigy Corporation 1-aryl-2-fluoro-2-azolyl alkanones, alkanols, esters, and ethers, composition containing them, and use of them to control phytopathogenic microorganisms

Also Published As

Publication number Publication date
EP0118245A1 (en) 1984-09-12
PT78128A (en) 1984-03-01
PL142674B1 (en) 1987-11-30
IL71042A (en) 1987-07-31
DK369889A (da) 1989-07-27
DE3463655D1 (en) 1987-06-19
PL246356A1 (en) 1985-02-27
HK32389A (en) 1989-04-28
JPS59193877A (ja) 1984-11-02
NZ207256A (en) 1986-07-11
YU33584A (en) 1986-08-31
HU190545B (en) 1986-09-29
FI840764A (fi) 1984-08-26
SU1405701A3 (ru) 1988-06-23
NO161559B (no) 1989-05-22
PT78128B (en) 1986-07-17
DD216457A5 (de) 1984-12-12
IN161372B (xx) 1987-11-21
FI840764A0 (fi) 1984-02-24
KR870000356B1 (ko) 1987-03-05
DK97884D0 (da) 1984-02-24
DK160823C (da) 1991-10-07
DK171233B1 (da) 1996-08-05
ZA841322B (en) 1985-10-30
KR840008018A (ko) 1984-12-12
IE57056B1 (en) 1992-04-08
DK369889D0 (da) 1989-07-27
IE840451L (en) 1984-08-25
CA1257276A (en) 1989-07-11
FI80683C (fi) 1990-07-10
GR79816B (xx) 1984-10-31
AU545660B2 (en) 1985-07-25
US4960782A (en) 1990-10-02
CS127684A2 (en) 1985-06-13
JPS6411631B2 (xx) 1989-02-27
FI80683B (fi) 1990-03-30
AU2504084A (en) 1984-08-30
HUT34012A (en) 1985-01-28
IL71042A0 (en) 1984-05-31
GB8305377D0 (en) 1983-03-30
DK160823B (da) 1991-04-22
SG6589G (en) 1989-06-09
YU42634B (en) 1988-10-31
NO840721L (no) 1984-08-27
EP0118245B1 (en) 1987-05-13
ES8506653A1 (es) 1985-07-16
DK97884A (da) 1984-08-26
PH20060A (en) 1986-09-18
CS241047B2 (en) 1986-03-13
ES529992A0 (es) 1985-07-16

Similar Documents

Publication Publication Date Title
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO163451C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminomethyloxooxazolidinylbenzenderivater.
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO162764C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO156864B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO162514C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO164301C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO164169C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzothiazinderivater.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO161738C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive imidazolinderivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO160512C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.